Destekleyici Onkoloji Bakımında Dijital Araçlar ve Yapay Zekâ
Synopsis
This chapter reviews the current applications of digital health technologies and artificial intelligence in supportive oncology care. It examines the role of smartwatches and other wearable devices in monitoring physical activity, sleep, weight changes, and body composition, alongside mobile applications, remote patient monitoring systems, and electronic patient-reported outcome (ePRO) platforms. The potential of machine learning and natural language processing for the early identification of chemotherapy-related toxicities, pain, hospitalization risk, and psychosocial concerns is also discussed. Digital symptom monitoring may facilitate timely clinical interventions and has demonstrated benefits in quality of life and healthcare utilization in selected studies. However, important challenges remain, including data security, patient privacy, digital health literacy, algorithmic bias, external validation, and integration into clinical workflows. Overall, digital technologies should be considered complementary tools that support rather than replace clinical judgment, with the potential to promote more personalized, proactive, and patient-centered supportive oncology care.
References
Holl F, Kircher J, Hertelendy AJ, Sukums F, Swoboda W. Tanzania's and Germany's Digital Health Strategies and Their Consistency With the World Health Organization's Global Strategy on Digital Health 2020-2025: Comparative Policy Analysis. J Med Internet Res. 2024;26:e52150. doi: 10.2196/52150.
Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016;375(2):154-61. doi: 10.1056/NEJMra1601705.
Mathews SC, McShea MJ, Hanley CL, Ravitz A, Labrique AB, Cohen AB. Digital health: a path to validation. NPJ digital medicine. 2019;2(1):38.
Heudel P, Ubelmann C. Leveraging Digital Technology to Enhance Mind-Body Approaches in Cancer Treatment. JCO Clin Cancer Inform. 2025;9:e2400293. doi: 10.1200/cci-24-00293.
Marthick M, McGregor D, Alison J, Cheema B, Dhillon H, Shaw T. Supportive Care Interventions for People With Cancer Assisted by Digital Technology: Systematic Review. J Med Internet Res. 2021;23(10):e24722. doi: 10.2196/24722.
Wilde LJ, Ward G, Sewell L, Müller AM, Wark PA. Apps and wearables for monitoring physical activity and sedentary behaviour: A qualitative systematic review protocol on barriers and facilitators. Digital health. 2018;4:2055207618776454.
Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. JNCI: Journal of the National Cancer Institute. 2017;109(9):djx029.
Esteva A, Chou K, Yeung S, Naik N, Madani A, Mottaghi A, et al. Deep learning-enabled medical computer vision. NPJ Digit Med. 2021;4(1):5. doi: 10.1038/s41746-020-00376-2.
Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nature medicine. 2019;25(1):24-9.
Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Briefings in bioinformatics. 2018;19(6):1236-46.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56. doi: 10.1038/s41591-018-0300-7.
Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Supportive care in cancer. 2020;28(10):4589-612.
Mooney K, Beck SL, Wilson C, Coombs L, Whisenant M, Moraitis AM, et al. Assessing patient perspectives and the health equity of a digital cancer symptom remote monitoring and management system. JCO Clinical Cancer Informatics. 2024;8:e2300243.
Piwek L, Ellis DA, Andrews S, Joinson A. The Rise of Consumer Health Wearables: Promises and Barriers. PLoS Med. 2016;13(2):e1001953. doi: 10.1371/journal.pmed.1001953.
Gresham G, Hendifar AE, Spiegel B, Neeman E, Tuli R, Rimel BJ, et al. Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients. NPJ Digit Med. 2018;1:27. doi: 10.1038/s41746-018-0032-6.
Brouwer CG, Douma JAJ, Kuip EJM, Zweegman S, van de Donk N, Hopman MTE, et al. Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials. J Natl Compr Canc Netw. 2024;22(5):323-30. doi: 10.6004/jnccn.2024.7001.
Akdogan O, Uyar GC, Bergerot CD, McCollom JW, Tuzcu TU, Yesilbas E, et al. Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer. Support Care Cancer. 2026;34(10). doi: 10.1007/s00520-026-11216-6.
Cheville AL, Kollasch J, Vandenberg J, Shen T, Grothey A, Gamble G, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage. 2013;45(5):811-21. doi: 10.1016/j.jpainsymman.2012.05.006.
Friesner ID, Feng J, Kalnicki S, Garg M, Ohri N, Hong JC. Machine Learning-Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step Counts. JAMA Oncol. 2024;10(5):642-7. doi: 10.1001/jamaoncol.2024.0014.
Manz CR, Schriver E, Ferrell WJ, Williamson J, Wakim J, Khan N, et al. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial. J Med Internet Res. 2024;26:e51059. doi: 10.2196/51059.
Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28(2):292-8. doi: 10.1200/jco.2009.22.5011.
Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35(2):237-45. doi: 10.5665/sleep.1630.
Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, et al. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 2014;22(9):2535-45. doi: 10.1007/s00520-014-2204-5.
Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI. Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage. 2014;47(4):721-30. doi: 10.1016/j.jpainsymman.2013.05.010.
Moscato S, Ostan R, Giannelli A, Varani S, Chiari L. Symptom Monitoring in Oncological Patients Using Wrist-Worn Wearables: A Machine Learning Approach. Annu Int Conf IEEE Eng Med Biol Soc. 2025;2025:1-6. doi: 10.1109/embc58623.2025.11253240.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489-95. doi: 10.1016/s1470-2045(10)70218-7.
Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Battaglini CL, Williams GR. Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review. Oncologist. 2020;25(2):170-82. doi: 10.1634/theoncologist.2019-0600.
Kato R, Miyamoto Y, Hiyoshi Y, Maeda Y, Ouchi M, Ogawa K, et al. Pretreatment bioelectrical impedance analysis predicts chemotherapy efficacy and toxicity in metastatic colorectal cancer patients. Clin Nutr ESPEN. 2025;66:497-504. doi: 10.1016/j.clnesp.2025.02.015.
Cereda E, Casirati A, Klersy C, Nardi M, Vandoni G, Agnello E, et al. Bioimpedance-derived body composition parameters predict mortality and dose-limiting toxicity: the multicenter ONCO-BIVA study. ESMO Open. 2024;9(8):103666. doi: 10.1016/j.esmoop.2024.103666.
Sim I. Mobile Devices and Health. N Engl J Med. 2019;381(10):956-68. doi: 10.1056/NEJMra1806949.
Rockey-Bartlett C, Morelli J, Coffel M, Geracitano J, Lafata JE, Khairat S. Effect of remote patient monitoring on healthcare use among patients with cancer: A systematic review. Digit Health. 2025;11:20552076251384220. doi: 10.1177/20552076251384220.
Cloß K, Verket M, Müller-Wieland D, Marx N, Schuett K, Jost E, et al. Application of wearables for remote monitoring of oncology patients: A scoping review. Digit Health. 2024;10:20552076241233998. doi: 10.1177/20552076241233998.
Canali S, Schiaffonati V, Aliverti A. Challenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fairness. PLOS Digit Health. 2022;1(10):e0000104. doi: 10.1371/journal.pdig.0000104.
Duin JJ, Baltussen JC, Albalak G, van Dam van Isselt EF, Portielje JEA, Mooijaart SP, et al. The use of wearable technology in studies in older adults with cancer: a systematic review. Oncologist. 2025;30(8). doi: 10.1093/oncolo/oyae319.
Sendak M, Gao M, Nichols M, Lin A, Balu S. Machine Learning in Health Care: A Critical Appraisal of Challenges and Opportunities. EGEMS (Wash DC). 2019;7(1):1. doi: 10.5334/egems.287.
Froicu EM, Oniciuc OM, Afrăsânie VA, Marinca MV, Riondino S, Dumitrescu EA, et al. The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology. Diagnostics (Basel). 2024;14(18). doi: 10.3390/diagnostics14182074.
Peterson DJ, Ostberg NP, Blayney DW, Brooks JD, Hernandez-Boussard T. Machine Learning Applied to Electronic Health Records: Identification of Chemotherapy Patients at High Risk for Preventable Emergency Department Visits and Hospital Admissions. JCO Clin Cancer Inform. 2021;5:1106-26. doi: 10.1200/cci.21.00116.
Pantano F, Manca P, Armento G, Zeppola T, Onorato A, Iuliani M, et al. Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study. JCO Precis Oncol. 2020;4. doi: 10.1200/po.20.00158.
van Buchem MM, de Hond AAH, Fanconi C, Shah V, Schuessler M, Kant IMJ, et al. Applying natural language processing to patient messages to identify depression concerns in cancer patients. J Am Med Inform Assoc. 2024;31(10):2255-62. doi: 10.1093/jamia/ocae188.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2016;34(6):557-65. doi: 10.1200/jco.2015.63.0830.
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. Jama. 2017;318(2):197-8. doi: 10.1001/jama.2017.7156.
Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, et al. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025;31(4):1225-32. doi: 10.1038/s41591-025-03507-y.
Wójcik Z, Dimitrova V, Warrington L, Velikova G, Absolom K. Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From Patient-Reported Outcome Measures. JCO Clin Cancer Inform. 2024;8:e2300264. doi: 10.1200/cci.23.00264.